- Home
- GEOS vs CNTX Comparison
GEOS vs CNTX Comparison
Compare GEOS & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEOS
- CNTX
- Stock Information
- Founded
- GEOS 1980
- CNTX 2015
- Country
- GEOS United States
- CNTX United States
- Employees
- GEOS N/A
- CNTX N/A
- Industry
- GEOS Industrial Machinery/Components
- CNTX Biotechnology: Pharmaceutical Preparations
- Sector
- GEOS Industrials
- CNTX Health Care
- Exchange
- GEOS Nasdaq
- CNTX Nasdaq
- Market Cap
- GEOS 72.9M
- CNTX 78.0M
- IPO Year
- GEOS 1997
- CNTX 2021
- Fundamental
- Price
- GEOS $12.40
- CNTX $0.69
- Analyst Decision
- GEOS
- CNTX Strong Buy
- Analyst Count
- GEOS 0
- CNTX 5
- Target Price
- GEOS N/A
- CNTX $5.50
- AVG Volume (30 Days)
- GEOS 500.4K
- CNTX 151.1K
- Earning Date
- GEOS 08-07-2025
- CNTX 08-06-2025
- Dividend Yield
- GEOS N/A
- CNTX N/A
- EPS Growth
- GEOS N/A
- CNTX N/A
- EPS
- GEOS N/A
- CNTX N/A
- Revenue
- GEOS $116,542,000.00
- CNTX N/A
- Revenue This Year
- GEOS N/A
- CNTX N/A
- Revenue Next Year
- GEOS N/A
- CNTX N/A
- P/E Ratio
- GEOS N/A
- CNTX N/A
- Revenue Growth
- GEOS N/A
- CNTX N/A
- 52 Week Low
- GEOS $5.51
- CNTX $0.49
- 52 Week High
- GEOS $18.99
- CNTX $2.75
- Technical
- Relative Strength Index (RSI)
- GEOS 55.56
- CNTX 57.14
- Support Level
- GEOS $12.60
- CNTX $0.62
- Resistance Level
- GEOS $14.38
- CNTX $0.67
- Average True Range (ATR)
- GEOS 1.80
- CNTX 0.05
- MACD
- GEOS -0.32
- CNTX 0.01
- Stochastic Oscillator
- GEOS 38.67
- CNTX 89.29
About GEOS Geospace Technologies Corporation (Texas)
Geospace Technologies Corp is engaged in designing and manufacturing seismic instruments and non-seismic equipment used in the oil and gas industry. The company has three different segments: oil and gas markets, adjacent markets, and emerging markets. The oil and gas markets segment, which accounts for the majority of the company's revenue, includes traditional exploration products, wireless exploration products, and reservoir characterization products and services. The adjacent markets business is closely tied to the oil and gas markets and includes imaging products and industrial products. The company operates globally across Asia, Canada, Europe, the United States, South America, Mexico, and other regions with a majority of its revenue being generated within the United States.
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.